| Financial Year |
March 31 2023 |
| Monetary Funds |
152,483,582.08 |
| Held-for-trading Financial Assets |
3,315,163.06 |
| Notes Receivable |
8,061,367.20 |
| Accounts Receivable |
475,510,498.87 |
| Advances to Suppliers |
106,401,765.04 |
| Other Receivables |
16,838,200.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
668,783,788.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,608,523.92 |
| Total Current Assets |
1,815,038,547.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,993,729.24 |
| Investment Properties |
-- |
| Fixed Assetes |
1,588,041,585.49 |
| Under-construction Projects |
180,950,799.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
173,988,534.17 |
| R&D expenses |
-- |
| Goodwill |
70,901,016.60 |
| Long-Term Deferred and Prepaid Expenses |
19,724,232.53 |
| Deferred Income Tax Assets |
14,135,315.58 |
| Other Non-Current Assets |
48,392,860.16 |
| Sub-Total of Non-Current Assets |
2,236,422,824.80 |
| Total Assets |
4,051,461,372.44 |
| Short-Term Loans |
127,811,833.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
127,349,361.85 |
| Accounts Payable |
230,126,255.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,400,295.58 |
| Taxes Payable |
25,667,302.41 |
| Interest Payable |
-- |
| Dividend Payable |
1,035,552.00 |
| Other payables |
42,595,693.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
385,985,928.28 |
| Other Current Liabilities |
4,692,894.20 |
| Sub-Total of Current Liabilities |
977,903,946.19 |
| Long-term Loans |
337,949,114.48 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
66,670,720.23 |
| Other Non-Current Liabilities |
32,231.73 |
| Sub-Total of Non-Current Liabilities |
412,979,204.14 |
| Total Liabilities |
1,390,883,150.33 |
| Paid-In Capital(Or Share Stock) |
509,016,166.00 |
| Capital Surplus |
635,922,467.62 |
| Surplus Reserve |
132,941,613.17 |
| LESS:Treasury Stock |
22,545,360.00 |
| Undistributed Profits |
1,366,672,645.76 |
| Minority Stockholder's Interest |
37,414,505.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,623,163,716.77 |
| Owner's Equity（Stockholder's Equity） |
2,660,578,222.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,051,461,372.44 |
